Specialized macrophages link gut lymphoid follicles to Crohn’s disease granulomas
By integrating multi-omics and functional assays, this study reveals that Crohn's disease granulomas originate from repurposed gut lymphoid follicles and are organized by distinct macrophage niches—specifically PLA2G2D-expressing cells at the periphery and SPP1-expressing cells in the core—that drive T-cell recruitment and fibrotic remodeling.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
The human intestine is not merely a tube for digestion; it is the body's largest immune organ, a bustling landscape where the body must constantly decide what to tolerate and what to fight. To manage this delicate balance, the gut is dotted with small, organized islands of immune cells called isolated lymphoid follicles. Think of these as quiet training grounds where immune cells learn to distinguish harmless food particles from dangerous invaders. In a healthy state, these follicles help maintain peace. However, in Crohn's disease, a chronic and often debilitating condition, this peace is shattered. The immune system goes into overdrive, creating large, destructive clumps of inflammation known as granulomas. These granulomas are a hallmark of the disease, often signaling a more severe course that can lead to surgery, yet scientists have long struggled to understand exactly how they form or why they look the way they do.
A new study by researchers in Barcelona has peeled back the layers of this mystery by looking at the gut tissue with unprecedented detail. By combining advanced mapping techniques that show where cells are located with genetic analysis that reveals what those cells are doing, the team discovered that these destructive granulomas do not appear out of nowhere. Instead, they seem to evolve from the very same lymphoid follicles that usually keep the gut healthy. The researchers found that in Crohn's disease, the signals that normally maintain these quiet training grounds are hijacked by inflammation, transforming them into the chaotic, scar-forming structures seen in severe disease.
The team began by examining tissue samples from healthy individuals and patients with Crohn's disease, using a method that allows them to see the precise location of every cell type within the tissue. They identified distinct neighborhoods of cells, much like different districts in a city. In healthy tissue, they found the expected lymphoid follicles, populated by immune cells working together. In the diseased tissue, they found these same follicles, but also the distinct, dense clusters of granulomas. By comparing the two, they realized that the granulomas shared a striking architectural similarity with the lymphoid follicles, suggesting that the disease process repurposes these existing structures rather than building new ones from scratch.
The most significant discovery lay in the specific types of immune cells, known as macrophages, that populate these areas. Macrophages are the body's cleanup crew and first responders, but the study revealed that they are not all the same. The researchers identified a previously unknown type of macrophage that expresses a specific protein called PLA2G2D. These cells were abundant in the healthy lymphoid follicles and were also found at the edges of the granulomas in Crohn's disease. They act as a bridge, linking the normal immune training grounds to the disease state. In contrast, a different type of macrophage, which produces a protein called SPP1, was found exclusively in the deep cores of the granulomas. These SPP1 cells appeared to be driven by different signals, such as low oxygen levels, and were closely associated with cells that build scar tissue, explaining why granulomas often lead to fibrosis and scarring.
To understand what drives these cells to change their behavior, the researchers tested how they responded to various chemical signals in the laboratory. They found that the PLA2G2D macrophages, which are normally found in the lymphoid follicles, are induced by signals that help organize immune tissue, such as lymphotoxin and LIGHT. However, when these same cells are exposed to tumor necrosis factor, a key inflammatory signal, they change their function. They begin to produce a chemical called CXCL9, which acts like a beacon, calling in other immune cells to the site of inflammation. This suggests that the granuloma forms when the signals that usually keep the lymphoid follicles organized are overwhelmed by inflammatory triggers, causing the cells to switch from a maintenance role to an aggressive, recruitment role.
The study also clarified why these two types of macrophages end up in different parts of the granuloma. The PLA2G2D cells, driven by inflammatory signals, settle at the periphery, gathering other immune cells. Meanwhile, the SPP1 cells, driven by low oxygen and other stress signals, take up residence in the center, interacting with fibroblasts to promote the hardening and scarring of the tissue. This spatial separation creates a highly organized, albeit pathological, structure. The researchers confirmed these findings by looking at actual patient tissue, where they could see the PLA2G2D cells surrounding the granulomas and the SPP1 cells buried deep within them, often next to the scar-forming cells.
This work provides a new model for understanding Crohn's disease, suggesting that the severe granulomas seen in patients are not random accidents but are the result of a specific transformation of the gut's natural immune structures. The study indicates that the disease process co-opts the body's own lymphoid follicles, twisting their normal organization into a site of chronic inflammation and scarring. While the researchers note that their findings are based on a specific set of samples and require further validation in larger groups, the evidence strongly points to a mechanism where distinct chemical signals dictate the fate of macrophages, determining whether they remain part of a healthy immune defense or become the architects of destructive granulomas. By mapping these cellular neighborhoods and the signals that drive them, the study offers a clearer picture of the disease's architecture, potentially opening the door to therapies that could interrupt the specific signals that turn a protective immune response into a damaging one.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.